Novel antifungal agents in clinical trials

Invasive fungal diseases due to resistant yeasts and molds are an important and increasing public health threat, likely due to a growing population of immunosuppressed hosts, increases in antifungal resistance, and improvements in laboratory diagnostics.  The significant morbidity and mortality asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobs, Samantha E., Zagaliotis, Panagiotis, Walsh, Thomas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787557/
https://www.ncbi.nlm.nih.gov/pubmed/35136573
http://dx.doi.org/10.12688/f1000research.28327.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787557/
https://www.ncbi.nlm.nih.gov/pubmed/35136573
http://dx.doi.org/10.12688/f1000research.28327.2

Ejemplares similares